Polymorphonuclear-Mononuclear Ratio in Peripheral Blood as Hematologic Malignancy Predictor in Pancytopenia

Authors

  • Indah Meyliza Department of Clinical Pathology, Faculty of Medicine, Universitas Sebelas Maret/ Dr. Moewardi General Hospital, Surakarta
  • JB. Suparyatmo Department of Clinical Pathology, Faculty of Medicine, Universitas Sebelas Maret/ Dr. Moewardi General Hospital, Surakarta
  • Dian Ariningrum Department of Clinical Pathology, Faculty of Medicine, Universitas Sebelas Maret/Dr. Moewardi General Hospital, Surakarta

DOI:

https://doi.org/10.24293/ijcpml.v30i1.2050

Keywords:

Pm/M ratio, pancytopenia, BMP

Abstract

Pancytopenia is a laboratory finding of decreased hematological cells characterized by hemoglobin of <13.5 g/dL for males or <11.5 g/dL for females, leukocytes of <4x109/L and platelets of <150x109/L. The data from Dr. Moewardi Hospital reported 56 cases of pancytopenia in 2020. Follow-up tests such as reticulocyte test, Bone Marrow Puncture (BMP), or bone marrow biopsy are needed to determine the cause of pancytopenia. This study aimed to assess the performance of the Pm/M ratio of peripheral blood as a screening instrument to predict the cause of pancytopenia. A cross-sectional study was carried out on pancytopenia patients undergoing laboratory tests at the Clinical Pathology Laboratories of Dr. Moewardi Hospital from January 2020 to June 2021. The cut-off point of the Pm/M ratio was determined by ROC and AUC curves. The results were presented in a 2x2 table. The Pm/M ratio <0.91 as a predictor of hematological malignancy had a sensitivity of 82.9%, specificity of 82.9%, PPV 82.9, NPV 82.9%, LR positive 4.833 and LR negative 0.207. The Pm/M ratio can be used as a screening biomarker to predict the cause of pancytopenia before performing BMP and to distinguish between hematological malignancy and non-hematological malignancy.

Downloads

Download data is not yet available.

Author Biography

Indah Meyliza, Department of Clinical Pathology, Faculty of Medicine, Universitas Sebelas Maret/ Dr. Moewardi General Hospital, Surakarta

Dokter Polisi Spesialis Patologi Klinik di RS Bhayangkara Tk. IV Polda Papua Barat.

References

Jyoti SK, Badhe BA, Dutta TK, Sajjan J. Clinicopathological study of adult pancytopenia with special reference to bone marrow biopsy. International Journal of Blood Disorder & Disease, 2019; 3(1): 1-5.

Trinil S, Ferry HS, Arifoel H. Leukocyte interference on hemoglobin examination in hematology malignancy. Indonesia Journal of Clinical Pathology and Medical Laboratory. 2017; 23(3): 203-207.

Raina JS, Kundal R, Puri P, Puri A, Kumar K, Attri HK. Correlation between different blood investigations-peripheral blood film and bone marrow findings in cases of pancytopenia. International Journal of Research and Review, 2020; 7(1): 47-53.

Carretero CJ, Vargas OE, Magana AL, Ortega JA, Guerrero CS, Chairez E. Etiology and clinico-hematological profile of pancytopenia: Experience of a Mexican Tertiary Care Center and review of the literature. Hematology, 2019; 24(1): 399-404.

Sallman DA, Padron E. Myelodysplasia in younger adults: Outlier or unique molecular entity?. Haematologica, 2017; 102(6): 967.

Hirsch CM, Przychodzen BP, Radivoyevitch T, Patel B, Thota S, et al. Molecular features of early onset adult myelodysplastic syndrome. Haematologica, 2017; 102(6): 1028.

Khodadadi L, Cheng Q, Radbruch A, Hiepe F. The maintenance of memory plasma cells. Frontiers in Immunology, 2019; 10. Available from: https://doi.org/10.3389/fimmu.2019.00721 (accessed June 6, 2021).

Sridevi HB, Rai S, Suresh PK, Somesh MS, Minal J. Pancytopenia in multiple myeloma-an enigma: our experience from tertiary care hospital. Journal of Clinical and Diagnostic Research (JCDR), 2015; 9(11): EC04.

Contejean A, Resche RM, Tamburini J, Alcantara M, Jardin F, Lengline E, Fontbrune FS. Aplastic anemia in the elderly: A nationwide survey on behalf of the French Reference Center for Aplastic Anemia. Blood, 2018; 132: 1298.

Contejean A, Resche-Rigon M, Tamburini J, Alcantara M, Jardin F, et al. Aplastic anemia in the elderly: A nationwide survey on behalf of the French Reference Center for Aplastic Anemia. Haematologica, 2018; 104(2): 256–262. Available from: https://doi.org/10.3324/haematol.2018.198440 (accessed June 6, 2021).

Contejean A, Resche-Rigon M, Tamburini J, Alcantara M, Jardin F, et al. Aplastic anemia in the elderly: A nationwide survey on behalf of the French Reference Center for Aplastic Anemia. Haematologica, 2018; 104(2): 256–262. Available from: https://doi.org/10.3324/haematol.2018.198440 (accessed June 6, 2021).

Hussain M, Boyer K, Ponnapalli A, Awuah D, Khaneki S, Deliwala S, Bachuwa G. Serotonin surge: Intravenous escitalopram as a rare cause of drug-induced aplastic anaemia. EJCRIM, 2022; 9(3): 003228.

Singh P, Sinha A, Kamath A, Malhotra S, Chandra AB. Aplastic anemia-a quick review. J Cancer Prev Curr Res, 2017; 7(5): 1-6.

Gaspar BL, Sharma P, Das R. Anemia in malignancies: Pathogenetic and diagnostic considerations. Hematology, 2015; 20(1): 18-25.

Shah R, Patel K. Evaluation of bone marrow in patients with pancytopenia. Panacea Journal of Medical Science, 2020; 10 (3): 209-215.

Garcia-Manero G. Myelodysplastic syndromes: 2023 update on diagnosis, risk stratification, and management. American Journal of Hematology. 2023. Available from: https://doi.org/10.1002/ajh.26984 (accessed July 7, 2023).

Colovic N, Dencic Fekete M, Perunicic M, Jurisic V. Clinical characteristics and treatment outcome of hypocellular acute myeloid leukemia based on WHO classification. Indian J Hematol Blood Transfus, 2020; 36(1): 59-63.

Kiyoi H, Kawashima N, Ishikawa Y. FLT3 mutations in acute myeloid leukemia: Therapeutic paradigm beyond inhibitor development. Cancer Sci, 2020; 111(2): 312-322.

Zimmermann P, Ziesenitz VC, Curtis N, Ritz N. The immunomodulatory effects of Macrolides—A Systematic review of the underlying mechanisms. Frontiers in Immunology, 2018; 9. https://doi.org/10.3389/fimmu.2018.00302 (accessed July 7, 2023).

Darwiche D, Iskandar K, Azar R, Hallit R, Hallit S. Piperacillin-Tazobactam-induced neutropenia: A case report. Journal of Medical Cases, 2017; 8(9): 280–282.

Roig SC, Braster Q, Gomez OA, Soehnlein O. Neutrophils as regulators of cardiovascular inflammation. Nature Reviews Cardiology, 2020; 17(6): 327-340.

Hoyer FF, Nahrendorf M. Neutrophil contributions to ischaemic heart disease. European Heart Journal, 2017; 38(7): 465-472.

Kurup R, Patel S. Neutrophils in acute coronary syndrome. EMJ Cardiol, 2017; 5(1): 79-87.

Lin A, Lore K. Granulocytes: New members of the antigen presenting cell family. Frontiers in Immunology, 2017; 8: 1781.

Sun L, Babushok DV. Secondary myelodysplastic syndrome and leukemia in acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria. Blood, 2020; 136(1): 36-49.

Yao H, Wu C, Chen Y, Guo L, Chen W, et al. Spectrum of gene mutations identified by targeted next generation sequencing in Chinese leukemia patients. Molecular Genetics & Genomic Medicine, 2020; 8(9): e1369.

Percival ME, Lai C, Estey E, Hourigan CS. Bone marrow evaluation for diagnosis and monitoring of acute myeloid leukemia. Blood Reviews, 2017; 31(4): 185-192.

Downloads

Submitted

2022-11-05

Accepted

2023-08-14

Published

2023-11-03

How to Cite

[1]
Meyliza, I., Suparyatmo, J. and Ariningrum, D. 2023. Polymorphonuclear-Mononuclear Ratio in Peripheral Blood as Hematologic Malignancy Predictor in Pancytopenia. INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY. 30, 1 (Nov. 2023), 12–17. DOI:https://doi.org/10.24293/ijcpml.v30i1.2050.

Issue

Section

Articles